1 / 8

Global Irritable Bowel Syndrome market to grow at a CAGR of 14.04 percent over the period 2014-2019

Big Market Research has announced a new Report Package "Global Irritable Bowel Syndrome Market -Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential"<br><br>Get Complete Details At: http://www.bigmarketresearch.com/global-irritable-bowel-syndrome-2015-2019-market<br> <br>Irritable bowel syndrome is a common disorder of the digestive system causing abdominal cramps, discomfort, bloating, constipation, and diarrhea. Inflammatory bowel disease, which is a chronic disease with recurrent immune response and inflammation of the GI tract, is sometimes confused with irritable bowel syndrome.<br><br>Enquire About this report At: http://www.bigmarketresearch.com/report-enquiry/169977

stefania_lori
Download Presentation

Global Irritable Bowel Syndrome market to grow at a CAGR of 14.04 percent over the period 2014-2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Irritable Bowel Syndrome Market 2015-2019 Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast 2019 Published Date: Nov 2014

  2. Report Description About Irritable Bowel Syndrome Irritable bowel syndrome is a common disorder of the digestive system causing abdominal cramps, discomfort, bloating, constipation, and diarrhea. Inflammatory bowel disease, which is a chronic disease with recurrent immune response and inflammation of the GI tract, is sometimes confused with irritable bowel syndrome. The symptoms of irritable bowel syndrome generally appear in a patient aged around 30 years. According to the CDC, prominent symptoms of irritable bowel syndrome include severe bloating, severe stomach cramps or abdominal pain, lower back pain, groin pain, heartburn, acidity, shooting pain in the legs, and lightheadedness after eating. The Global Irritable Bowel Syndrome market to grow at a CAGR of 14.04 percent over the period 2014-2019. Get Complete Report At: http://www.bigmarketresearch.com/global-irritable-bowel-syndrome-2015-2019-market Covered in this Report This report covers the present scenario and the growth prospects of the Global Irritable Bowel Syndrome market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various generic and branded therapies used in the treatment of irritable bowel syndrome.

  3. Report Description Global Irritable Bowel Syndrome Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Irritable Bowel Syndrome market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key Regions • Americas • APAC • EMEA Key Vendors • Actavis • AstellasPharma • Nestle • Takeda Pharmaceutical Enquire About This Report At: http://www.bigmarketresearch.com/report-enquiry/169977

  4. Report Description Other Prominent Vendors • Abbott • Alba Therapeutics • Alfa Wassermann • Alizyme • Almirall • AltheRx Pharmaceuticals • Ardelyx • AstraZeneca • Bayer • Bristol Myers Squibb • Dainippon Sumitomo Pharma • Dong-A Socio Holdings • Drais Pharmaceuticals • Dynogen • gIcarePharma • GlaxoSmithKline • Hanmi Pharmaceuticals • ImmusanT • Ironwood

  5. Report Description • Janssen • Lexicon Pharmaceuticals • Menarini • MicroDoseTherapeutx • Norgine • Novartis • Ocera Therapeutics • Ono Pharmaceutical • Par Pharmaceutical • Pfizer • Pharmos • Protagonist Therapeutics • RaQualiaPharma • Rottapharm • Salix • SeldarPharma • Shire • SK Chemicals • SOFAR • Synergy Pharmaceuticals • Synthetic Biologics

  6. Report Description Market Driver • Presence of Unmet Need • For a full, detailed list, view our report Market Challenge • High Cost of Therapy • For a full, detailed list, view our report Market Trend • Rise in Public Awareness • For a full, detailed list, view our report Key Questions Answered in this Report • What will the market size be in 2018 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors?

  7. Table Of Contents 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Product Profiles 05. Market Research Methodology 06. Introduction 07. Market Landscape 08. Market Segmentation by Mechanism of Action 09. Market Segmentation by Dosage Form 10. Market Segmentation by Indication 11. Market Segmentation by End User Gender 12. Geographical Segmentation 13. Rate of Incidence and Prevalence 14. Buying Criteria 15. Market Growth Drivers 16. Drivers and their Impact 17. Market Challenges 18. Impact of Drivers and Challenges Get Complete TOC At: http://www.bigmarketresearch.com/global-irritable-bowel-syndrome-2015-2019-market

  8. FOR MORE DETAILS Visit us at : http://www.bigmarketresearch.com/global-irritable-bowel-syndrome-2015-2019-market Stay With Us: 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States • TELEPHONE: +1 (855) 711-1555E-MAIL: help@bigmarketresearch.com

More Related